A Randomized Trial of Rifaximin vs Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome
A Randomized Trial of Rifaximin vs Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome. // Clinical Gastroenterology and Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1542356526003162?dgcid=rss_sd_all
A Randomized Trial of Rifaximin vs Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. https://www.sciencedirect.com/science/article/pii/S1542356526003162?dgcid=rss_sd_all
“A Randomized Trial of Rifaximin vs Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome.” Clinical Gastroenterology and Hepatology.
@article{article118496,
title = {A Randomized Trial of Rifaximin vs Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome},
journal = {Clinical Gastroenterology and Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1542356526003162?dgcid=rss_sd_all}
}